Spyre Therapeutics Inc.

NASDAQ: SYRE · Real-Time Price · USD
16.93
0.07 (0.42%)
At close: Aug 15, 2025, 3:59 PM
16.95
0.12%
After-hours: Aug 15, 2025, 07:36 PM EDT

Spyre Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-5.26 -0.44 -0.45 -4.75
PEG Ratio
0.05 -0.01 0.71 0.14
PS Ratio
n/a 167.52 16.28 16.67
PB Ratio
2.11 0.81 0.75 3.72
P/FCF Ratio
-6.96 -1.49 -0.47 -5.75
P/OCF Ratio
-6.96 -1.49 -0.47 -5.81
OCF/S Ratio
n/a -112.77 -34.41 -2.87
Debt / Equity Ratio
n/a 0.46 0.09 0.06
Quick Ratio
11.26 10.68 4.25 4.91
Current Ratio
11.26 10.68 4.25 4.91
Asset Turnover
n/a 0.00 0.03 0.17
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.4 -1.84 -1.67 -0.78
Return on Assets
-0.34 -0.99 -1.18 -0.6
Return on Invested Capital
-0.38 -0.78 -1.48 -0.73
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a -0.09 0.16 0.89
Net Profit Margin
n/a -382.38 -35.99 -3.51
Pretax Profit Margin
n/a -382.41 -36.05 -3.5
Operating Profit Margin
n/a -273.48 -36.4 -3.5
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a -144.27 -35.73 -3.4